Pazopanib with Topotecan Weekly for Patients with Platinum-Resistant or Intermediate-Sensitive Recurrent Ovarian Cancer: Results of a Multicentre, Open Label Phase I/II Study (TOPAZ)
Journal of Cancer Research and Clinical Oncology（2023）
Key words
Platinum-resistant ovarian cancer,Topotecan,Pazopanib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined